Stock listing

NASDAQ:AMAM Ambrx Biopharma Inc. Stock

Follow Ambrx Biopharma Inc. into a list and get an email when it puts out news.

Last close · NASDAQ:AMAM

$28.00 USD

Close on Mar 6, 2024 · No longer trades

Jun 18, 2021 to last close +64.2% · weekly closes, Jun 18, 2021 – Mar 6, 2024
Lowest – highest close
$0.41 – $28.09 USDSince Jun 18, 2021 · lowest Dec 8, 2022 · highest Jan 11, 2024

Delisted NASDAQ:AMAM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:AMAM
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Ambrx Biopharma Inc. on 6ix

Decks
5 decks · latest Feb 15, 2024

Decks

DeckKindSlidesDate
Merger or Acquisition (February 2024)Merger or acquisition18 slidesFeb 15, 2024
Investor Presentation (April 2023)Investor deck32 slidesApr 10, 2023
Investor Day (February 2023)Investor day19 slidesFeb 24, 2023
Corporate Update (October 2022)Corporate update21 slidesOct 18, 2022
Investor Presentation (November 2021)Investor deck31 slidesNov 8, 2021

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Paul V. Maier
Other companies: Eton Pharmaceuticals, Inc. (Eton Pharmaceutical Audit Committee Chairman · Since at least Nov 9, 2018); International Stem Cell Corporation (Independent Director · Since at least Jul 19, 2007); AIxCrypto Holdings, Inc. (Director · Jun 24, 2015 – Jan 15, 2020 · Past); MabVax Therapeutics Holdings Inc (Director · Apr 2, 2015 – Apr 2, 2018 · Past); Apricus Biosciences Inc (Director · Jun 1, 2012 – Jan 4, 2018 · Past); Talon Therapeutics Inc (Director · Apr 1, 2011 – Jul 17, 2013 · Past); Sequenom Inc (Chief Financial Officer · Nov 10, 2009 – Feb 10, 2014 · Past); PURE Bioscience (Director · Jan 22, 2008 – Jul 31, 2012 · Past); Ligand Pharmaceuticals Incorporated (Sr. V-P, CFO · Mar 10, 2006 – Nov 20, 2006 · Past)
Director · Jan 1, 2023 – Mar 7, 2024 · Past
Stephen C. Glover
Other companies: Oncolytics Biotech Inc. (Director · Since at least Jun 1, 2026); ZyVersa Therapeutics, Inc. (Co-founder, Chairman, CEO, and President · Since at least Dec 12, 2022); PDS Biotechnology Corporation (Director · Since at least Apr 2, 2019); Insmed Incorporated (President Follow-on Biologics · Jun 22, 2007 – Mar 31, 2009 · Past)
Director · May 18, 2023 – Mar 7, 2024 · Past
Daniel O’Connor
Other companies: DiaMedica Therapeutics Inc. (Director · Since at least Feb 20, 2025); ZyVersa Therapeutics, Inc. (Director · Dec 20, 2021 – Dec 12, 2022 · Past)
President and CEO, Director · Jan 1, 2023 – Mar 7, 2024 · Past
Edward Hu
Other companies: Viela Bio Inc (Director · Oct 2, 2019 – Mar 13, 2021 · Past); Tanox Inc (Chief Operating Officer · Feb 15, 2006 – Nov 28, 2006 · Past)
Director · Jan 1, 2023 – Jan 1, 2023 · Past
Sonja Nelson
Other companies: Motus GI Holdings, Inc. (Director · Jun 22, 2021 – Mar 5, 2024 · Past); ImmunityBio, Inc. (Chief Financial Officer · Aug 2, 2019 – Jan 12, 2021 · Past)
Chief Financial Officer · Jan 1, 2023 – Mar 7, 2024 · Past
Andrew Aromando
Other companies: Oncolytics Biotech Inc. (Chief Business Officer · Since at least Jun 30, 2025)
Chief Operating Officer · Apr 28, 2023 – Mar 7, 2024 · Past
Katrin Rupalla
Other companies: ZyVersa Therapeutics, Inc. (Director · Jan 5, 2023 – Jan 5, 2023 · Past)
Director · Jan 1, 2023 – Jan 27, 2023 · Past
Margaret Dalesandro
Other companies: Skye Bioscience, Inc. (Director · Aug 7, 2020 – Feb 29, 2024 · Past)
Director · Sep 1, 2023 – Mar 7, 2024 · Past
Janet LoesbergDirector · Jan 1, 2023 – Mar 7, 2024 · Past
Kate HermansDirector · Jan 1, 2023 – Mar 7, 2024 · Past
All 11 people
PersonSeat
Xiaowei ChangDirector · Jan 1, 2023 – Jun 7, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Ambrx Biopharma Inc.